These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Human Exserohilum and Bipolaris infections: report of Exserohilum nasal infection in a neutropenic patient with acute leukemia and review of the literature. Douer D, Goldschmied-Reouven A, Segev S, Ben-Bassat I. J Med Vet Mycol; 1987 Aug; 25(4):235-41. PubMed ID: 3312557 [Abstract] [Full Text] [Related]
24. Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study. Walsh TJ, Rubin M, Hathorn J, Gress J, Thaler M, Skelton J, McKnight J, Browne M, Marshall D, Cotton D. Arch Intern Med; 1991 Apr; 151(4):765-70. PubMed ID: 2012462 [Abstract] [Full Text] [Related]
25. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial. Subirà M, Martino R, Gómez L, Martí JM, Estany C, Sierra J. Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069 [Abstract] [Full Text] [Related]
33. Response of thiazide-induced hypokalemia to amiloride. Maronde RF, Milgrom M, Vlachakis ND, Chan L. JAMA; 1983 Jan 14; 249(2):237-41. PubMed ID: 6848810 [Abstract] [Full Text] [Related]
34. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE. N Engl J Med; 2004 Sep 30; 351(14):1391-402. PubMed ID: 15459300 [Abstract] [Full Text] [Related]
35. Amphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients. Johansen HK, Gotzsche PC. Cochrane Database Syst Rev; 2000 Sep 30; (3):CD000239. PubMed ID: 10908468 [Abstract] [Full Text] [Related]
36. [Amphotericin B for treatment of fungal infections in 40 patients with malignant hematologic diseases]. Yang Z, Jiang B, Ren H. Zhonghua Nei Ke Za Zhi; 2001 Nov 30; 40(11):757-9. PubMed ID: 11930683 [Abstract] [Full Text] [Related]
37. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study. Kelsey SM, Goldman JM, McCann S, Newland AC, Scarffe JH, Oppenheim BA, Mufti GJ. Bone Marrow Transplant; 1999 Jan 30; 23(2):163-8. PubMed ID: 10197802 [Abstract] [Full Text] [Related]
38. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients. Kibbler CC. Mycoses; 1999 Jan 30; 42 Suppl 2():121-4. PubMed ID: 10865918 [Abstract] [Full Text] [Related]
39. Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy. Schuler U, Bammer S, Aulitzky WE, Binder C, Böhme A, Egerer G, Sandherr M, Schwerdtfeger R, Silling G, Wandt H, Glasmacher A, Ehninger G. Onkologie; 2007 Apr 30; 30(4):185-91. PubMed ID: 17396041 [Abstract] [Full Text] [Related]
40. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group. Wolff SN, Fay J, Stevens D, Herzig RH, Pohlman B, Bolwell B, Lynch J, Ericson S, Freytes CO, LeMaistre F, Collins R, Pineiro L, Greer J, Stein R, Goodman SA, Dummer S. Bone Marrow Transplant; 2000 Apr 30; 25(8):853-9. PubMed ID: 10808206 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]